Skip to content
PPD Contract Research for Thermo Fisher Scientific
Main Menu
  • Careers
  • Newsroom
  • Investors
  • Japan
  • English
    • Français Canadien
  • Search
  • Contact Us
Search
  • Who We Are
    • Our Mission
      • Accolades
      • Our History
    • Our 4i Values
    • Our Work
      • Our Solutions
      • How We Help
      • Therapeutic Areas
    • Corporate Responsibility
      • Environmental Stewardship
      • Health and Wellness
      • Philanthropy
      • PPD Heroes
    • Locations
    • Company Resources
      • Vendor Resources
      • Legal Notices
      • Privacy Notice
      • Events
      • Newsroom
      • Ethics
      • Investors
  • How We Help
    • Accelerator™ Drug Development
    • Clinical Research Outsourcing Solutions
    • Chronic Disease
    • Expertise in Asia-Pacific
      • PPD in China
      • PPD-SNBL in Japan
    • Industry Trends
    • Precision Medicine
    • Real-World Representation in Clinical Trials
  • Our Solutions
    • Clinical Development
      • Government and Public Health
      • Patient First Solutions
        • Digital and Decentralized
        • Patient Recruitment & Engagement
        • Real-World Representation in Clinical Trials
        • Global Contact Center Solutions
      • Digital and AI
        • Clinical Decision Suite
        • Clinical Trial Forecasting Suite
        • Preclarus
      • Phase II-IV Clinical Trial Management
        • Biostatistics
        • Clinical Data Management
        • Clinical Trial Monitoring
        • Clinical Trial Project Management
        • Global Clinical Supplies
        • Interventional Studies
        • Medical Writing
        • Pharmacokinetic and Pharmacodynamic
        • Pharmacovigilance
      • Real-World Evidence
        • Observational Studies
        • Real-World Data and Scientific Solutions
        • Pregnancy and Lactation Studies
        • PPD Evidera Patient-Centered Research
        • PPD Evidera Implementation Science
      • Proprietary Real-World Data
        • PPD CorEvitas Clinical Registries
        • PPD CorEvitas Precision Medicine
        • PPD Vestrum Health Real-World Data
      • PPD Evidera Health Economics and Market Access
        • PPD Evidera Health Economics
        • PPD Evidera Market Access 
      • PPD Biotech Solutions
      • PPD Functional Service Partnership Solutions
        • Biostatistics and Programming
        • Clinical Data Management
        • Clinical Operations
        • Feasibility
        • Global Clinical Supplies
        • Medical Writing
        • Pharmacovigilance
        • Project Delivery
        • Regulatory Affairs
        • Site Contracts and Payments
        • Site Support
        • Study Startup
        • Quality Assurance
        • Insights Hub: PPD FSP Solutions
      • PPD Translate Solutions
      • Medical Communications
      • Regulatory Affairs Solutions
    • PPD Laboratory Services
      • Bioanalytical Lab
        • Bioanalytical Lab Capabilities
        • Bioanalytical Lab Experience and Expertise
        • Bioanalytical Lab Tech Talks
        • Bioanalytical Lab Resources
      • Biomarker Solutions
        • Biomarker Expertise and Capabilities
      • Central Lab
        • Central Lab Capabilities
        • Certifications
        • Preclarus Lab Solutions
        • Central Lab Resources
      • GMP Lab
        • GMP Lab Capabilities
        • GMP Lab Experience and Expertise
        • Athlone Lab
        • GMP Lab Resources
      • Vaccine Sciences Lab
        • Vaccine Sciences Lab Capabilities
        • Vaccine Sciences Lab Resources
      • Lab Services Therapeutic Expertise
      • Lab Services in China
      • Lab Services in Europe
      • Scientific Resourcing
  • Therapeutic Expertise
    • Biosimilar Development
    • Cardiovascular
    • Cell & Gene Therapy
    • Critical Care
    • Dermatology
    • Hepatology
    • Gastroenterology
    • Immunology and Rheumatology
      • Lupus
    • Infectious Diseases
    • Metabolic and Endocrine
      • Diabetes
      • Rare Metabolic Disease
    • Nephrology and Renal Diseases
    • Neuroscience Research
      • Neurodegenerative Disease Research Expertise
      • Psychiatry
      • Neuroinflammatory Diseases
    • Oncology and Hematology
    • Ophthalmology
    • Pediatrics
    • Rare Diseases
      • Rare Hematology and Oncology
      • Rare Metabolic
      • Rare Neurological
      • Rare Neuromuscular
      • Rare Respiratory
    • Respiratory
    • Urology
    • Vaccine Development
    • Women’s Health
  • Insights Hub
  • Participate in a Trial
rendering of small molecules

Upcoming Conferences

Who We Are Company Resources Events Upcoming Conferences
Upcoming Conferences
  • All Events
  • Past Conferences
19th EBF Open Symposium

17 Nov - 19 Nov 2026 Barcelona, Spain Booth #: 2-B

Details and Registration
Edinburgh, Scotland
DDL 2026

09 Dec - 11 Dec 2026 Edinburgh, Scotland Booth #: 207

Details and Registration
new orleans skyline
American Society of Hematology (ASH) 2026

12 Dec - 15 Dec 2026 New Orleans, Louisiana Booth #: 1129

Details and Registration
  • Legal Notices
  • Site Map
  • Modern Slavery Transparency Statement
  • Privacy Notice
©2026 Thermo Fisher Scientific Inc. All Rights Reserved.
  • Contact Us
  • LinkedIn
  • Twitter
  • Facebook
  • Instagram
  • YouTube
  • Events

Find your ideal clinical development outsourcing solution

Question 1 of 6

    Your ideal solution is an FSP solution

    Our functional service provider (FSP) partnerships provide support for a specific function or functions—such as clinical operations or pharmacovigilance—across protocols, medicinal products, a portfolio of studies, or a company.

    Our FSP engagements use a flexible mix of systems, processes, oversight and facilities–yours or ours. Contracts are typically allotted by function rather than by study and use cost models based on full-time equivalents (FTEs), units, or time and materials. In the FTE model, our personnel typically work directly within a sponsor’s existing SOPs and platforms.

    PPD FSP solutions are a good fit for sponsors who would like closer control and visibility of clinical development operations and who have the infrastructure to assume greater management responsibility. This model also helps sponsors expand their capabilities or capacity using top-tier talent, while, at the same time, leveraging their own internal strengths and capabilities.

    Learn more about PPD FSP solutions

    Your ideal solution is an FSO arrangement

    Our full-service outsourcing (FSO) arrangements involve the complete, end-to-end outsourcing of clinical trial tasks—from study startup through database lock—established on a study or protocol basis.

    These engagements leverage the full depth of our capabilities as needed—people, systems and processes—to support trials at any phase, from early development through Phase II and III and into peri- and post-approval.

    FSO arrangements are ideal for sponsors who lack specific study-related expertise or the resources necessary to execute the trial themselves. Projects are overseen and executed by project managers at the PPD™ clinical research business of Thermo Fisher Scientific, reducing the sponsor’s management burden.

    Learn more about our FSO arrangements

    Your ideal solution is a mixed FSP/FSO model

    Our mixed functional service provider (FSP) partnership/full-service outsourcing (FSO) solutions combine the two models to create bespoke solutions tailored to meet your specific needs.

    These arrangements often include single or multiple FSP offerings added to an existing FSO arrangement on an as-needed basis—or combined from the very start to create a custom solution. Mixed FSP/FSO models may be delivered from one or multiple CROs; be established by protocol, portfolio of studies, or company; and provide support on both short- and long-term timelines (e.g., complementing a multiple-year FSO partnership with shorter contracted FSP services).

    Mixed FSP/FSO models use your systems and SOPs, our systems and SOPs, or a combination of the two, and may be executed through a single—or mixed—cost model. Mixed FSP/FSO models are often used to support sponsors who want greater control of a critical or strategically important clinical development function or when additional resources or specific capabilities are needed to meet unexpected demands to keep projects on time and on budget (e.g., expansion into new regions, therapeutic areas, functions, and services). Mixed FSP/FSO models may also bridge the transition period when shifting from FSO to FSP outsourcing.

    Learn more about our mixed FSP/FSO models

    If you’re looking for a seamless transition to an experienced FSP provider, let’s connect.

    If you’re looking for a seamless transition to an experienced full-service outsourcing partner, let’s connect.

    If you’re looking for a seamless transition to an experienced outsourcing partner that delivers bespoke mixed FSP/FSO model solutions, let’s connect.

    Thanks — we’ll be in touch

    Someone from the team will follow up shortly.